Nasdaq:US$9.51 (-0.07) | HKEX:HK$16.36 (-0.66) | AIM:£1.54 (-0.05)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 3 Oct 2013

Analyst briefing on Chi-Med’s pharmaceutical R&D business on 9 October 2013